Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
Condition(s):VitiligoLast Updated:March 22, 2013Completed
Hide Studies Not Open or Pending
Condition(s):VitiligoLast Updated:March 22, 2013Completed
Condition(s):Erythropoietic ProtoporphyriaLast Updated:October 28, 2019Completed
Condition(s):Erythropoietic ProtoporphyriaLast Updated:October 12, 2021Completed
Condition(s):Solar UrticariaLast Updated:September 15, 2009Completed
Condition(s):Actinic Keratoses; Carcinoma, Squamous Cell; Organ Transplant RecipientsLast Updated:December 6, 2010Unknown status
Condition(s):Polymorphic Light Eruption (PLE)Last Updated:October 5, 2011Completed
Condition(s):VitiligoLast Updated:October 31, 2023Recruiting
Condition(s):Variegate PorphyriaLast Updated:January 25, 2024Completed
Condition(s):Xeroderma PigmentosumLast Updated:September 21, 2023Recruiting
Condition(s):Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy VolunteersLast Updated:February 9, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.